Drug Delivery

Small molecule oncology drug market to exceed $66bn in 2019

12-Jul-2019 By Maggie Lynch

A recent study from Fact.MR reported that sales of oncology small molecule drugs are forecasted to exceed $66bn in 2019, up from $63bn in 2018.

Erytech-SQZ collaboration to ‘realize immune-modulating potential’

11-Jul-2019 By Maggie Lynch

Erytech entered an agreement with SQZ to advance RBC-based therapeutics for immune modulation using the latter’s platform.

Gilead and Lyndra co-develop long-acting HIV therapies

11-Jul-2019 By Vassia Barba

Following Gilead’s funding of Lyndra’s technology, the latter company offers exclusive rights to its therapeutics platform for long-acting HIV therapies formulations.

Lonza enters a collaborative agreement with Auxly for capsule formulation

01-Jul-2019 By Maggie Lynch

Lonza will supply Auxly with materials and proprietary manufacturing equipment for capsule filling and sealing through collaborative agreement.

Dr Reddy’s in 'timely divestiture' of neurology products for $110m

18-Jun-2019 By Ben Hargreaves

Dr Reddy’s enters asset purchase agreement with Upsher-Smith to sell rights for its neurology products, Zembrace and Tosymra.

‘Significant benefit’ to drug delivery excipient leads to deal

13-Jun-2019 By Ben Hargreaves

PeptiDream agrees a strategic partnership with PharmaIN to utilise its PGC delivery technology for its peptide discovery and development programs.

Aptar scoops up two pharma services firms in $50m deal

11-Jun-2019 By Melissa Fassbender

Aptar Group acquires two pharmaceutical services companies, Nanopharm and Gateway Analytical, to boost its analytical, testing, and development capabilities.

Cambrex completes $11m labs and logistics center expansion

11-Jun-2019 By Vassia Barba

Cambrex announces the completion of a 600-square-meter facility in Karlskoga, Sweden, alongside a 3,000-square-meter warehouse.

Amgen and Takeda join to form five-strong drug delivery partnership

06-Jun-2019 By Ben Hargreaves

Amgen and Takeda will join fellow big pharma companies Sanofi, GSK, and Janssen, in working to progress Feldan’s intracellular drug delivery technology.

Lilly joins the push for non-opioid painkillers

03-Jun-2019 By Maggie Lynch

Eli Lilly acquires exclusive worldwide rights for non-opioid treatment for chronic pain from Centrexion through a licensing agreement.

EMA puts spotlight on antimicrobial resistance as river contamination spreads

30-May-2019 By Vassia Barba

EMA assembles pharmaceutical developers to strengthen antimicrobial pipelines while, in the meantime, a study found the world’s rivers dangerously contaminated.

Cytonus’ tech helps oncolytic viruses evade immune system

29-May-2019 By Ben Hargreaves

Cytonus will present at BIO regarding the development of Cargocytes, which offer a delivery system for immunotherapy treatments.

Amgen acquires Nuevolution after 'high-speed' development progress

27-May-2019 By Vassia Barba

Amgen acquires Nuevolution for $167m to boost its drug discovery platform, following a previous three-year collaboration.

Scancell utilises nanotechnology to amp up solid tumour vaccine

23-May-2019 By Ben Hargreaves

Scancell and Cancer Research UK use nanodelivery technology to activate the body’s immune system, boosting its ability to target and destroy cancer cells.